TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients ...
India held an 8% share in global clinical trials - which evaluate the safety and effectiveness of new treatments - compared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback